Published in Proteomics Weekly, November 24th, 2003
"Advanced colon cancer is a malignancy with poor response to various treatment modalities including ionizing radiation (IR) and chemotherapy. Both IR and chemotherapeutic agents have been shown to act by inducing apoptosis, a type of cell death antagonized by the Bcl-x(L) gene product. Since approximately 60% of human colon cancers express Bcl-x(L), it was the aim of this study to explore the potential of Bcl-x(L) antisense oligonucleotides as a novel radiosensitization strategy," scientists in Austria report.
"Caco-2 colon cancer cells were treated with Bcl-x(L) antisense...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly